NKILT

NKILT Therapeutics is developing a novel allogeneic, off-the-shelf approach to engineering immune cells, starting with natural killer (NK) cells, to directly target leukemias and solid tumors... NKILT Therapeutics is a cell therapy biotech in seed stage with an allogeneic, off-the-shelf approach targeting cancer with natural receptor binding.

Also known as: NKILT Therapeutics, NKILT, Inc.

Primary location: Houston United States